Cas12a-based electrochemiluminescence biosensor for target amplification-free DNA detection

CRISPR/Cas system have drawn increasing attention in accurate and sensitive nucleic acids detection. Herein, we reported a novel Cas12a-based electrochemiluminescence biosensor for target amplification-free human papilloma virus subtype (HPV-16) DNA detection. During this detection process, Cas12a employed its two-part recognition mechanism to improve the specificity and trans-cleavage capability to achieve signal amplification, while L-Methionine stabilized gold nanoclusters (Met-AuNCs) were served as high-efficiency ECL emitters to achieve ECL signal transition. Given the unique combination of Cas12a with ECL technique, the detection limit was determined as 0.48 pM and the whole detection could be completed within 70 min. We also validated the practical application of the proposed biosensor by using undiluted human blood samples, which gives impetus to the design of new generations of CRISPR/Cas detection system beyond the traditional ones with ultimate applications in sensing analysis and diagnostic technologies.

Automated summary

A novel Cas12a-based electrochemiluminescence biosensor was developed for target amplification-free HPV-16 DNA detection, with a detection limit of 0.48 pM and completion within 70 min. This unique combination of Cas12a with ECL technique shows promise for future applications in sensing analysis and diagnostic technologies beyond traditional CRISPR/Cas detection systems.